Understanding Human Pluripotent Stem Cell States and Their Applications with Thorold Theunissen
Thorold Theunissen, Ph.D., of the Washington University School of Medicine in St. Louis shares his work using naive stem cells to model trophoblast development. Video Transcript: [MUSIC] My lab studies human pluripotent stem cells. We’re especially interested in understanding different stem cell states and their applications. Recently, we’ve become really excited about using naive stem […]
Stem Cell Assays Market Report 2022-2027: Government Initiatives to Boost Stem Cell Research Present Opportunities
DUBLIN, July 7, 2022 /PRNewswire/ — The “Stem Cell Assays Market by Type (Viability, Proliferation, Differentiation, Apoptosis), Cell Type (Mesenchymal, iPSCs, HSCs, hESCs), Product & Service (Instrument), Application (Regenerative Medicine, Clinical Research), End User – Global Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering. The stem cell assay market is projected to reach […]
Akari Therapeutics Announces First Patient to Complete Course of Treatment in the Phase III Part A Clinical Trial of Investigational Nomacopan in Pediatric Hematopoietic Stem Cell Transplant-Related Thrombotic Microangiopathy (HSCT-TMA)
NEW YORK and LONDON, July 07, 2022 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biotechnology company focused on developing advanced therapies for autoimmune and inflammatory diseases, today announced that a patient has completed the course of investigational nomacopan treatment in the open-label, multi-center Phase III Part A clinical trial in pediatric hematopoietic stem cell transplant-related […]
ISSCR 2022: On the Ground | The Stem Cell Podcast
In this special episode of the Stem Cell Podcast, Daylon and Arun talk with delegates at the ISSCR 2022 annual meeting. The attendees discuss the memorable research presented and share their thoughts on the challenges facing the stem cell field.
Inceptor Bio Announces Strategic Collaboration with University of Minnesota to Develop Novel iPSC Platform for the Advancement of Next-Generation Allogeneic Cell Therapies
MORRISVILLE, N.C., June 30, 2022 /PRNewswire/ — Inceptor Bio, a biotechnology company advancing cell therapies for difficult-to-treat cancers, today announced a collaboration with University of Minnesota. The aim of this collaboration is to build a novel induced pluripotent stem cells (iPSC) platform that will accelerate Inceptor Bio’s best-in-class next-generation cell therapies platforms. Under the terms of […]
The 2022 Ogawa-Yamanaka Stem Cell Prize Awarded to Juan Carlos Izpisua Belmonte
SAN FRANCISCO, June 28, 2022 /PRNewswire/ — Juan Carlos Izpisua Belmonte, PhD, was announced today as the recipient of the 2022 Ogawa-Yamanaka Stem Cell Prize by Gladstone Institutes. Izpisua Belmonte is director of the San Diego Institute of Science of Altos Labs, a new life sciences company focused on restoring cell health and resilience through […]
Animal Stem Cell Therapy Market projected CAGR of 5.2% for the next ten years (2022-2032) – Persistence Market Research
New York, June 27, 2022 (GLOBE NEWSWIRE) — The global animal stem cell therapy market recorded sales of around US$ 249.9 Mn in 2021 and the market is predicted to experience healthy growth over the years ahead at a CAGR of 5.2% (2022 to 2032). Animal stem cell therapies are treatments for disorders such as […]
Jasper Therapeutics to Present at the LifeSci Partners 2nd Annual Genetic Medicines Symposium
REDWOOD CITY, Calif., June 23, 2022 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (NASDAQ: JSPR), a biotechnology company focused on enabling cures with stem cell therapies, today announced that the Company will participate at the LifeSci Partners 2nd Annual Genetic Medicines Symposium on June 28, 2022. Ronald Martell, Chief Executive Officer, Jeet Mahal, Chief Operating & […]
Cincinnati Pain Management Physician Leads First Successful Stem Cell Controlled Trial with 70% of Participants Seeing Positive Results
CINCINNATI, June 15, 2022 /PRNewswire/ — Local Cincinnati pain physician Dr. Sairam Atluri led the first prospective controlled clinical trial on using bone marrow mesenchymal stem cells (BM-MSCs) for chronic pain. 70% of study participants gained significant pain relief and improved physical and mental function. The first of its kind in the world, the study was […]
GoodCell Offers Personal Biobanking Early Adopter Discount for a Limited Time
Waltham, MA, June 13, 2022 (GLOBE NEWSWIRE) — Today, GoodCell, a life sciences company, is announcing a limited-time early adopter discount for Personal Biobanking, a proactive, preventative healthcare service that allows members to store their own stem cells for future potential personalized cell therapies. GoodCell’s Personal Biobanking—similar to cord blood banking—is a subscription service. With the […]